Core Viewpoint - Weave Communications, Inc. (WEAV) is experiencing significant selling pressure, having declined 26.1% over the past four weeks, but is now positioned for a potential trend reversal as it enters oversold territory with strong analyst support for better-than-expected earnings [1] Group 1: Technical Indicators - The Relative Strength Index (RSI) is a momentum oscillator that indicates whether a stock is oversold, with readings below 30 typically signaling this condition [2] - WEAV's current RSI reading is 27.34, suggesting that the heavy selling may be exhausting itself, indicating a potential bounce back towards equilibrium [5] Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that WEAV's earnings estimates for the current year have increased by 29.8% over the last 30 days, which usually correlates with price appreciation [7] - WEAV holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the stock's potential for a turnaround [8]

Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e. buying assets at a discount e.g. net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e. buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get starte ...

Weave Communications (NYSE: WEAV) published its latest earnings release on Friday, and it'll probably spend the weekend wishing it hadn't. Mr. Market wasn't happy about the company's slight bottom-line miss, and punished Weave by selling out of its equity. By the end of the day, the company's shares had fallen by almost 5%. Focused on health Weave, which specializes in communications solutions for healthcare businesses, released its final set of 2025 figures. The fourth quarter saw the company earn reven ...

分组1 - Weave Communications, Inc. reported quarterly earnings of $0.03 per share, matching the Zacks Consensus Estimate, with an earnings surprise of -9.91% compared to the previous year [1] - The company posted revenues of $63.4 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 0.52%, and showing an increase from $54.17 million year-over-year [2] - Weave Communications has surpassed consensus revenue estimates four times over the last four quarters [2] 分组2 - The stock has underperformed, losing about 24.6% since the beginning of the year, while the S&P 500 has gained 0.5% [3] - The current consensus EPS estimate for the coming quarter is $0.02 on revenues of $64.67 million, and for the current fiscal year, it is $0.12 on revenues of $274.83 million [7] - The Internet - Software industry is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Financial Data and Key Metrics Changes - In Q4, the company achieved $63.4 million in total revenue, reflecting a 17% year-over-year growth, with gross margin reaching a record 73.3% [20][24] - Operating income for Q4 was $2.3 million, marking an improvement of over $500,000 compared to Q4 2024, resulting in an operating margin of 3.6% [23][30] - For the full year 2025, total revenue grew 17% to $239 million, with gross margin expanding to 72.7%, up 80 basis points from the previous year [30] Business Line Data and Key Metrics Changes - Weave Payments grew at more than twice the rate of total revenue in 2025, driven by new capabilities like automated payment reminders and bulk collections [16] - The specialty medical vertical became the second-largest vertical by location count, with significant growth in Q4 [16] Market Data and Key Metrics Changes - The company is in fewer than 15% of U.S. dental locations, indicating substantial growth potential in the dental market [19] - Specialty medical, which currently holds about 1% market share, is expected to be a significant growth area due to the introduction of AI-powered solutions [20] Company Strategy and Development Direction - The company aims to enhance patient experiences through a unified platform that reduces administrative burdens for healthcare professionals [5][6] - The acquisition of TrueLark is seen as a foundational step in expanding AI Receptionist capabilities, addressing staffing challenges in practices [13][19] - The company plans to roll out an omnichannel AI Receptionist in 2026, which will allow practices to manage patient interactions across various channels [14][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of revenue growth and margin expansion, emphasizing the importance of AI in enhancing operational efficiency [17][30] - The company anticipates continued strong growth in specialty medical and mid-market sectors, supported by recent investments in sales and marketing [22][31] Other Important Information - The company ended Q4 with $81.7 million in cash and short-term investments, reflecting strong liquidity [23] - The net revenue retention rate in Q4 was 93%, with gross revenue retention at 89%, indicating strong customer retention despite some challenges in newer verticals [24][28] Q&A Session Summary Question: Can you elaborate on the CareCredit integration? - The CareCredit partnership opens new avenues for capturing volumes that would otherwise flow through CareCredit, enhancing the payment solution's attractiveness [35][36] Question: What are your expectations for growth rates across different subverticals in 2026? - Management anticipates strong growth across specialty medical and mid-market sectors, with specialty medical expected to lead due to recent marketing efforts [37][38] Question: How do you plan to monetize the new AI capabilities? - The company is exploring whether to price new functionalities as additional modules or include them in existing bundles, confident in the ability to monetize the AI omnichannel receptionist [42][43] Question: Have churn rates stabilized in specialty medical cohorts? - Churn rates have shown improvement in Q4, returning to historical levels, with ongoing integrations expected to further enhance retention [44][45] Question: What are the investment priorities for the coming year? - Investment priorities include product and engineering, particularly in enhancing AI capabilities, as well as adjustments to the go-to-market strategy for efficiency [52][54] Question: How does Weave differentiate its AI capabilities from competitors? - Weave's unique advantages include ownership of the telephony stack, deep industry-specific workflows, and the ability to retain context across various patient interactions [56][58]

Financial Data and Key Metrics Changes - In Q4, the company achieved $63.4 million in total revenue, reflecting a 17% year-over-year growth, with gross margin reaching a record 73.3% [20][21] - For the full year, total revenue grew 17% to $239 million, and gross margin expanded to 72.7%, up 80 basis points from the previous year [30] - Operating income for Q4 was $2.3 million, representing an operating margin of 3.6%, an improvement of 30 basis points year-over-year [23] Business Line Data and Key Metrics Changes - Weave Payments grew at more than twice the rate of total revenue in 2025, driven by new capabilities like automated payment reminders and bulk collections [16] - The specialty medical vertical became the second-largest by location count, with significant growth in Q4, adding more locations than any previous quarter [16] Market Data and Key Metrics Changes - The company has expanded its estimated total addressable market (TAM) by approximately $7 billion to an estimated $22 billion following the acquisition of TrueLark [19] - The dental market remains a key focus, with Weave being endorsed by the American Dental Association, providing access to 160,000 members [20] Company Strategy and Development Direction - The company aims to enhance patient experiences through a unified platform that reduces administrative burdens for healthcare professionals [5][6] - Weave is focusing on AI-powered solutions to automate workflows, thereby improving operational efficiency and customer retention [9][10] - The acquisition of TrueLark is seen as a foundational step in enhancing AI receptionist capabilities, addressing staffing challenges in practices [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of revenue growth and margin expansion, highlighting the importance of ongoing investments in innovation [17][30] - The company anticipates strong growth in specialty medical and mid-market sectors, with expectations for continued momentum in 2026 [31][32] Other Important Information - The company ended Q4 with $81.7 million in cash and short-term investments, reflecting strong liquidity [23] - Free cash flow for the full year was $12.9 million, representing a 24% year-over-year growth [24] Q&A Session Summary Question: Can you elaborate on the CareCredit integration? - The CareCredit partnership opens avenues for capturing volumes that would otherwise flow through CareCredit, enhancing payment solutions for customers [35][36] Question: What are the growth expectations across different subverticals for 2026? - Management anticipates strong growth across specialty medical and mid-market sectors, with specialty medical expected to lead due to recent marketing efforts and integrations [37][38] Question: How do you plan to monetize the new AI capabilities? - The company is exploring whether to price new functionalities as additional modules or include them in existing bundles, confident in the ability to monetize the value delivered [42][43] Question: Have churn rates stabilized in older specialty medical cohorts? - Churn rates have shown improvement, returning to historical levels, with ongoing integrations contributing to this stabilization [44][45] Question: What are the investment and hiring priorities for the coming year? - The company prioritizes investments in product and engineering, particularly in AI and telephony, alongside adjustments in the go-to-market strategy for efficiency [52][54] Question: How does Weave differentiate its AI capabilities from competitors? - Weave's unique advantages include ownership of the telephony stack, deep industry-specific workflows, and the ability to retain context across interactions, setting it apart from competitors [56][58]

Financial Data and Key Metrics Changes - In Q4 2025, Weave Communications achieved a revenue growth of 17% year-over-year, with total revenue reaching $63.4 million [22] - Gross margin expanded to a record 73.3%, reflecting a year-over-year improvement of 70 basis points [22] - Operating income for Q4 was $2.3 million, marking an operating margin of 3.6%, which is a 30 basis point improvement from the previous year [25] - For the full year 2025, total revenue grew 17% to $239 million, and gross margin for the year expanded to 72.7%, up 80 basis points from the prior year [32] Business Line Data and Key Metrics Changes - Weave Payments grew at more than twice the rate of total revenue in 2025, driven by new capabilities like automated payment reminders and bulk collections [18] - The specialty medical vertical became the second-largest vertical by location count, with significant growth in Q4 [18] - The acquisition of TrueLark added AI receptionist capabilities, enhancing the product offering and expanding the total addressable market by approximately $7 billion to an estimated $22 billion [21] Market Data and Key Metrics Changes - Weave has been endorsed by the American Dental Association as its exclusive patient engagement solution, providing access to 160,000 members [22] - The company is in the early stages of penetration in the specialty medical market, currently holding roughly 1% market share [22] Company Strategy and Development Direction - The company aims to leverage AI to reduce administrative burdens for healthcare professionals, enhancing patient care and operational efficiency [6][10] - Weave plans to roll out an omni-channel AI receptionist across all vertical markets in 2026, which will allow practices to handle calls 24/7 [16] - The focus is on integrating AI capabilities into existing workflows to create a seamless experience for healthcare providers [60] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of revenue growth and margin expansion, highlighting the importance of customer success in driving long-term value [19] - The company anticipates continued strong growth in specialty medical and mid-market sectors, supported by recent investments in sales and marketing [40] - Management expects total revenue for Q1 2026 to be in the range of $64.2 million to $64.8 million, with an operating income of $1 million to $2 million [33] Other Important Information - The company ended Q4 with $81.7 million in cash and short-term investments, reflecting strong liquidity [25] - Free cash flow for the full year was $12.9 million, representing a 24% year-over-year growth [26] Q&A Session Summary Question: Can you talk about the CareCredit integration? - The CareCredit partnership opens avenues to capture volumes that would otherwise flow through CareCredit, enhancing the payment solution for practices [38] Question: What are your expectations for growth rates across different subverticals in 2026? - Management anticipates strong growth across specialty medical and mid-market sectors, with specialty medical expected to be the fastest-growing segment [40][41] Question: How do you plan to capture the value delivered by new AI capabilities? - The company is exploring monetization strategies for the AI receptionist, considering whether to price it as an additional module or include it in a bundle [45] Question: How do you see the impact of new products like TrueLark on net revenue retention? - The growth from the AI receptionist is expected to be more pronounced in the second half of 2026, with significant upsell opportunities anticipated [72]

Weave Overview Q4 2025 NYSE : WEAV FEBRUARY 2026 1 Safe Harbor Statement This presentation has been prepared by Weave Communications, Inc. ("Weave", "we", "us", or "our") for informational purposes only and not for any other purpose. This presentation contains "forward-looking statements" within the Private Securities Litigation Reform Act of 1995 that are based on our management's current expectations and projections about future events and financial trends that we believe may affect our financial conditio ...

• Total revenue was $63.4 million, representing a 17.0% year-over-year increase compared to $54.2 million in the fourth quarter of 2024. • GAAP gross margin was 72.7%, compared to 72.1% in 2024. • Non-GAAP gross margin was 73.3%, compared to 72.6% in 2024. • GAAP loss from operations was $2.2 million, compared to $7.4 million in the fourth quarter of 2024. • Non-GAAP income from operations was $2.3 million, compared to $1.8 million in the fourth quarter of 2024. • GAAP net loss was $1.8 million, or $0.02 pe ...

Core Viewpoint - Raymond James downgraded Weave Communications from Strong Buy to Outperform and reduced its price target to $10.00 from $12.00, reflecting a more challenging environment for small and mid-sized business software companies [1][2] Group 1: Company Performance and Initiatives - Weave continues to gain traction in growth initiatives, particularly in Specialty Medical, which has become its second-largest market by locations [2] - Progress in multi-office deployments includes a recent win covering over 600 locations, alongside a growing pipeline for its AI receptionist and automation solution, TrueLark [3] - Additional growth opportunities are identified through deeper integrations, improved product packaging, potential ARPC expansion via AI and payments offerings, and broader go-to-market partnerships [3] Group 2: Future Outlook - Although initiatives are expected to take time to materialize, there is a path toward re-accelerating growth and a return to a more consistent beat-and-raise pattern [4] - Shares are trading at 2x the 2026 sales estimate, but a full re-rating is unlikely until organic growth acceleration becomes more visible or the company shows a clearer path toward long-term profitability [4]